Dysfunctional teeth, donated by community dental clinics, were recycled for research on bone morphogenetic protein (BMP) in health and disease. The crown remnants were trimmed away, and the roots were washed in 70% alcohol, demineralized, lyophilized, and prepared in one of two forms: (1) human partially demineralized root dentin matrix (PDM) or (2) autolysed, antigenextracted root matrix (AAAD), including attached cementum. Composites of either PDM or antigen-extracted, autolysed, delipidized allogenic dentin matrix (AAAM) and recombinant human bone morphogenetic protein (rhBMP-2) were implanted in either normal or athymic mice. The percentage of muscle replaced by heterotopic bone was estimated by computer-assisted random point analysis. Implants of PDM and AAAD made from dysfunctional teeth exhibited little or no endogenous BMP activity and failed to induce new bone formation. Composites of 1 g of rhBMP-2 per 70 mg of PDM carrier induced 61% replacement of muscle by bone formation; 1 g of rhBMP-2 in 70 mg of AAAM matrix induced 78% replacement of muscle mass by bone; 2 or 5 g of rhBMP-2 and 70 mg of AAAM carrier induced 100% replacement of thigh muscle mass by bone. In athymic mice, the areas of new bone were only slightly greater than those in normal mice. These observations suggest that root dentin prepared from extracted teeth may be recycled for use as a carrier of rhBMP-2 because it induces new bone formation in the periodontium.
sites as partially purified, partially insoluble native (hBMP/NCP) and as highly purified soluble recombinant (recombinant human bone morphogenetic protein [rhBMP-2]) buffered to about pH 6. To retain the morphogen at the site of implantation long enough for the host-bed cells (of perivascular mesenchymal type) to gather, soluble rhBMP-2 is adsorbed to a carrier or to a delivery system. 12 The delivery system may also provide an adhesive substratum. In our experiments, the partially demineralized matrix (PDM) provided the mineral and matrix for adsorption of rhBMP-2. The antigenextracted, autolysed, delipidized allogeneic dentin matrix (AAAM) provided a substratum with minimal antigenic substances. The host mice were either normal (Swiss Webster strain) or athymic mice that were deficient in theda antigens, T-cells, and immunogenic reactions to BMP. 10 However, autogeneic fresh bone has the disadvantage of transplanting osteoclast progenitor cells, which, in some cases, causes resorption of the root structure of adjacent teeth.
Kawai and Urist 7 separated the pulp and the periodontal soft tissue from the hard tissues (enamel, dentin, and cementum) of 1-year-old steers and found high levels of osteoinductive activity. Becker et al 17 found very low or no endogenous osteoinductive activity in adult human DBM issued from clinical bone banks and pointed out the need for supplementary exogenous BMP for treatment of periodontal defects. Neiderwanger and Urist 18 implanted composites of human DBM and rhBMP-2 and demonstrated higher yields of induced bone formation than previously noted. Here, we report on two experimental rhBMP-2 carrier systems prepared from human tooth remnants. One system is surface-demineralized PDM designed to determine the effects of slow mineral resorption and release of rhBMP-2. The other system, AAAM, is designed to emit a low level of soluble antigenic proteins. The matrix mineral interface is assumed to contain substances and/or receptors that promote the BMP-induced bone development.
MATERIALS AND METHODS
rhBMP-2 (batch 2D11J024) was provided by Dr Vicki Rosen, and Dr John Wozney (Genetics Institute, Boston, Mass). Biological activity was verified in adult rats using intramuscular implants composed of rhBMP-2 and 6 M guanidine hydrochloric acid (GuHCl)deactivated rat bone matrix.
Implants of rhBMP-2 in a glycine buffer solution in gelatin capsules
Three sets of 4-week-old male Swiss Webster mice were recipients of 1, 2, and 5 g of rhBMP-2 in glycine-buffered solutions. The solutions were instilled in the open half of disassembled no. 5 gelatin capsules, were reassembled without any other carrier, and were then implanted in the hindquarter muscles of the mice. The same number of implants were placed in athymic mice. The number of animals in each treatment group and the quantity of induced bone development is shown in Table 1 .
Carriers for rhBMP-2
Root dentin matrix was prepared from human teeth donated by outpatients at the University of California School of Dentistry. Immediately after extraction, the roots were trimmed and cleaned of all extraneous material and sterilized in 70% alcohol. The roots were partially demineralized with 0.6 N hydrochloric acid for 24 hours at 2ЊC and were then cut into 0.5-g blocks. PDM, including cementum, was washed in cold water and lyophilized. PDM was also converted into antigenextracted autolysed matrix (AAAD) by methods employed for human use in previous reports. 19 The PDM and AAAD root matrices were cut into 1.0to 2.0-mm 3 blocks. Briefly stated, antigen was also extracted with chloroform methanol, the soluble noncollagenous proteins were autolysed and digested in 0.1 M phosphate-buffered saline, and bone collagen was converted to insoluble bone gelatin in 8 M lithium chloride.
Three sets of each composite dose of 70 mg of PDM or of AAAD plus 0, 1, 2, and 5 g of rhBMP-2, respectively, were implanted in normal and athymic mice (C Rivers Lab, North Wilmington, Mass).
Root AAAD powders
Two hundred milligrams of root AAAD were pulverized in a milling machine (Spex Ind, Metuchen, NJ) to a particle size of 100-200 m 3 . Samples weighing 70 mg, with and without 1, 2, or 5 g of rhBMP-2, were implanted in gelatin capsules in the 20 normal mice.
Histologic methods
The mice were sacrificed at 21 days. The hindquarters were x-rayed, and tissues were fixed in 10% neutral formalin, decalcified in ethylenediaminetetra-acetic acid (EDTA), sectioned in paraffin, and stained by hematoxylin, eosin, and azure II for histologic evaluation.
The areas of new bone, which displaced muscle, and the old unabsorbed matrix particles (Tables 1, 2) were measured with a grid micrometer on radiographs and on histological sections. The data were obtained by random point analysis computed as described in detail by Kawai The Student's t-test was applied to each carrier. The data were reported as the mean value and standard deviation. Sample sizes of groups 2, 3, and 4 were too small for statistical evaluation. The paired Student's t-test for unusual sample sizes was used to compare group 1 (rhBMP-2 solution in gelatin capsules) with group 2 (AAAD and rhBMP-2 in gelatin capsules).
RESULTS
The PDM and AAAM were implanted either en bloc or as powders in gelatin capsules in hindquarter muscles in both normal and athymic mice.
Normal mice
In the control group of normal mice, blocks of human PDM and AAAD dentin implanted in muscle caused no muscle to be replaced by new bone development. Implantation of 1 g of rhBMP-2 alone was absorbed without inducing bone development, while the response to implantation of 2 g of rhBMP-2 was bone replacement of muscle at a rate of 42%. The response to implantation of 5 g of rhBMP-2 was 59.7% replacement by new bone.
rhBMP-2-PDM composites
As a result of implantation of 1 g of rhBMP-2 plus PDM, the rate of muscle replacement by new bone was 61%. Bone replaced muscle at a rate of 83% with 2 g of rhBMP-2 plus PDM, and 100% replacement occurred with 5 g of rhBMP-2 plus PDM. Without rhBMP-2, PDM induced no new bone development.
rhBMP-2-AAAD composite Implantation of 1 g of rhBMP-2 using AAAD as a carrier produced bone replacement of the mouse hindquarter muscles at rates of 78 to 100%. Implantation of 2 and 5 g of rhBMP-2 with AAAD as a carrier both produced the same rates of replacement as the 1-g trial (78-100%; Table 1 ). Without rh-BMP-2, 70 mg of AAAD tooth matrix produced histologically detectable replacement at a rate of about 3%; that is, only slight endogenous native BMP activity that was hardly detectable in radiographs (Figs 1-4 ). Implants of root matrix dentin were rapidly resorbed and replaced by new bone at rates proportional to the quantity of exogenous rhBMP-2 in the implant. Bone development increased with increases of rhBMP from 1 to 2 to 5 g and was associated with progressive replacement of old matrix. With implantation of fine powders, the rates of the hindquarter replacement of muscle by bone were 40% with 1 and 2 g of rhBMP-2 and 63% with 5 g of rhBMP-2 ( Table 2 ). The percentage of unabsorbed matrix decreased in proportion to the area of new bone. Implantation of 2 g of rhBMP-2 with both PDM and AAAM carriers showed statistically significant equivalent responses (Figs 3-5 ).
HISTOLOGICAL OBSERVATIONS Implants of 2 g of rhBMP-2 without a carrier other than the gelatin capsules 
rhBMP-2-PDM and rhBMP-2-AAAD composites implanted in normal mice
Within 3 weeks, new bone deposits were remodeled and filled with he-matopoietic marrow. In some places, histological sections showed direct bone-to-carrier attachments with no intervening fibrous or inflammatory connective tissue. The volume of bone formation was directly proportional to the dose levels of rhBMP-2 in the ranges of 1, 2, and 5 g per 0.07 g of (PDM or AAAD) carrier (Figs 13, 14 ). Figures 15 and 16 show results of AAAD and PDM implantation (without rhBMP-2) in athymic mice after 3 weeks. Trace amounts of new bone attached to the exposed surfaces of the dentin were suggestive of sites of endogenous BMP activity (Fig 16) . Comparable deposits were not found in mice that had been implanted with PDM; instead, the PDM implants were enveloped in dense fibrous connective tissue (Figs 15-17) .
AAAD and PDM alone implants in the athymic mice

AAA tooth and PDM-rhBMP-2 composite implants in the athymic nude mice
Figures 18 and 19 show the histologic reactions to composites of 2 g of rhBMP in athymic mice. Both implants caused large deposits of new bone, including active bone marrow, as well as direct appositional bone deposition on the tooth surfaces of the implants in both the AAAD and the PDM composite subjects. Table 2 summarizes observations of the carrier function of AAAD pulverized to increase the surface area of absorption of rhBMP-2. Without rhBMP-2, AAAD powder was rapidly absorbed and was without any osteoinductive effects. With 1, 2, or 5 g of rhBMP-2 per 50 mg of AAAD powders, however, 40, 44, and 63% of the muscle matrix particles were displaced by bone, respectively. The reduction of the rate of replacement by bone associated with the implanted powder in the absence of rhBMP-2 was 66.7%. In the composite with 1 g of rhBMP-2 plus AAAM, the reduction rate was 32%, but dropped to 23% with 2 g of rhBMP-2 with AAAM, and to only 3% with 5 g of rhBMP-2 with AAAM. Figs 20 and 21.
This striking reciprocal relationship of the volume of new bone to the absorption of the AAAD carrier is shown in
DISCUSSION
The experiments on human adult extracted teeth presented here were de-signed to determine whether root matrix, including small patches of cementum may (1) induce heterotopic bone development and/or (2) serve as a carrier for rhBMP-2 induced bone development. A literature review showed that the following substances have also been investigated for carrier properties: human collagen, atelocollagen, albumin, osteonectin, osteocalcin, bone matrix, blood clot, polylactic polyglycolic acid polymers, calcium sulfate, hydroxyapatite, ␤-tricalcium phosphate, and titanium oxide. 20 Although endogenous BMP has been found in large quantities in dentin in normal young adult mammals, dentin matrix seems not to have been evaluated as a carrier of exogenous BMP. BMP activity declines in bone with aging, but whether or not BMP also declines in dentin with time and/or with periodontal disease requires investigation by quantitative methods. The surprising findings in our study were the large quantity of induced bone development and the complete resorption and replacement of root dentin matrix as compared with bone matrix development induced by the carriers, listed above.
The quantity of unresorbed matrix after 21 days was less than previously observed with implantation of either crown dentin or cortical bone matrix. 1, 2, 18, 21 Microscopic remnants of unresorbed root dentin matrix powders were osteointegrated, that is, embedded in bone trabecular like old bone in new bone in an autogeneic homostructural graft. 22 Extensive investigations of growth factors and BMP on shavings of cementum and dentin have been reported; rhBMP-2 induced connective tissue proliferation with attachments to cementum and bone. 23, 24 Sigurdsson et al 25 demonstrated that rhBMP-2 induced bone formation and periodontal bone regeneration in dogs. Arzate et al 26 isolated a partially purified cementum protein (with a molecular weight of 55 kDa) that stimulated chondrogen-esis and mineralization in cultures of mouse embryo forelimb buds. In that study, progenitor cells (presumably derived from periodontal ligaments and alveolar bone) differentiated into cartilage and bone. BMP expression was transient in both embryonic development and organogenesis of bones and teeth, as observed by in situ hybridization or immunohistochemical methods. 26, 27 The quantity of endogenous BMP in dysfunctional teeth was very small or nil compared with the large deposits of bone induced by 2 g of exogenous BMP. The antigenicity of recombinant BMP compared with native dentin BMP remains to be determined by quantitative immunohistochemical methods. 28, 29 Previous experiments with demineralized cortical bone matrix as a carrier 17, 18 showed no qualitative difference in response to partially purified native hBMP and rhBMP-2.
Microscopically, implants of pulverized root with cementum on one surface of some particles or on no surfaces or implants of cementum shavings in-FIGURE 21. Graphic representation of volume of new bone and percent of the remnants of root dentin powder in the implants of AAAM shown in proportion to the quantity of rhBMP-2 (1, 2, and 5 g). New bone deposits replaced from 40 to 60% of the hindquarter muscle mass. duced bone formation occurring in apposition to both cementum and noncementum surfaces. Wozney et al, 30 Sommerman et al, 31 Sommerman et al, 32 and Kagayama et al 33 (1997) made GuHCl and EDTA extracts of bovine cementum and other tissues known to contain BMP and observed stimulation of human gingival fibroblasts in vitro. Miki et al, 23 King et al, 34 Nishimura et al, 35 Kinoshita et al, 24 Vanio et al, 36 and Wang et al 37 observed an increase in DNA synthesis in culture media with and without supplements of BMP and other growth factors.
Conover and Urist 10 separated BMP from collagenase digests of gelatinized, demineralized dentin matrix of adult rabbits; the undigested residual matrix was rapidly resorbed and demonstrated very high levels of BMP activity. Fractionation of the collagenase resistant proteins produced a native BMP (with molecular weight of 30 and 23 kDa). Previously, Butler et al 3 isolated an insoluble noncollagenous BMP from a soluble phosphoprotein of dentin in rats, guinea pigs, and rabbits. Kawai and Urist 7 described water-insoluble BMPs with molecular weights of 15 to 28 kDa isolated from a pulverized mixture of enamel, dentin, and cementum of unerupted bovine teeth. The isoinductive activity of these BMPs was slightly higher than that of the BMPs isolated from cortical bone.
Present observations on root-matrixinduced bone development were derived from discarded dysfunctional teeth deficient in endogenous BMP. Some of the teeth were so decayed that only the root structure with a thin coat of cementum remained available for use as a carrier. Exogenous rhBMP-2 adsorbed to a pulverized root PDM or AAAM proved to be as osteoinductive as autogeneic bone. Whether or not a large periodontal alveolar bone defect may be repaired using composites of rhBMP and PDM or AAAM warrants special investigation.
